Center-Authored Papers

Filters: Author is Begg, Colin B  [Clear All Filters]
2017
Campbell PT, Rebbeck TR, Nishihara R, Beck AH, Begg CB, Bogdanov AA, Cao Y, Coleman HG, Freeman GJ, Heng YJ et al..  2017.  Proceedings of the third international molecular pathological epidemiology (MPE) meeting.. Cancer causes & control : CCC. Abstract
2015
Ogino S, Campbell PT, Nishihara R, Phipps AI, Beck AH, Sherman ME, Chan AT, Troester MA, Bass AJ, Fitzgerald KC et al..  2015.  Proceedings of the second international molecular pathological epidemiology (MPE) meeting.. Cancer causes & control : CCC. Abstract
2014
Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Friedman DN, Mubdi NZ, Leisenring WM, Stovall M, Hammond S et al..  2014.  Breast Cancer After Chest Radiation Therapy for Childhood Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
2013
Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS et al..  2013.  Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report.. European journal of cancer (Oxford, England : 1990). 49(14):2979-2985. Abstract
2011
Capanu M, Concannon P, Haile RW, Bernstein L, Malone KE, Lynch CF, Liang X, Teraoka SN, Diep AT, Thomas DC et al..  2011.  Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling.. Genetic epidemiology. 35(5):389-97. Abstract
2010
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN et al..  2010.  Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.. Breast cancer research and treatment. 123(2):491-8. Abstract
Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M et al..  2010.  Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(14):2404-10. Abstract
Borg A, Haile RW, Malone KE, Capanu M, Diep A, Törngren T, Teraoka S, Begg CB, Thomas DC, Concannon P et al..  2010.  Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.. Human mutation. 31(3):E1200-40. Abstract
Poynter JN, Langholz B, Largent J, Mellemkjaer L, Bernstein L, Malone KE, Lynch CF, Borg A, Concannon P, Teraoka SN et al..  2010.  Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.. Cancer causes & control : CCC. 21(6):839-46. Abstract
2009
Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, Reiner AS, Liang X et al..  2009.  Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study.. American journal of epidemiology. 169(8):962-8. Abstract
2008
Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF et al..  2008.  Variation of breast cancer risk among BRCA1/2 carriers.. JAMA : the journal of the American Medical Association. 299(2):194-201. Abstract
Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B et al..  2008.  Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.. Journal of the National Cancer Institute. 100(1):32-40. Abstract
Concannon P, Haile RW, Børresen-Dale A-L, Rosenstein BS, Gatti RA, Teraoka SN, Diep AT, Jansen L, Atencio DP, Langholz B et al..  2008.  Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.. Cancer research. 68(16):6486-91. Abstract